A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer

CMAJ. Canadian Medical Association Journal

Volumn 154, Issue 4, 1996, Pages 457-464

  Macdonald, Kathleen G ^a   Doan, Brian ^b   Kelner, Merrijoy ^b   Taylor, Kathryn M ^a  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE; BREAST CANCER; CANCER RISK; COLON CANCER; CULTURAL FACTOR; EMOTIONAL STRESS; FAMILIAL CANCER; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HEALTH PROMOTION; HUMAN; OVARY CANCER; PATIENT COMPLIANCE; SHORT SURVEY; SOCIAL ASPECT; SOCIAL BEHAVIOR; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; ARTICLE; BREAST TUMOR; COLON TUMOR; CULTURAL ANTHROPOLOGY; DISEASE PREDISPOSITION; FEMALE; GENETIC SCREENING; GENETICS; GENETICS AND REPRODUCTION; OVARY TUMOR; PSYCHOLOGICAL ASPECT;

GENETICS AND REPRODUCTION;

ATTITUDE; BREAST NEOPLASMS; COLONIC NEOPLASMS; CULTURE; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; OVARIAN NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 0029967101     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (124)

1. Malkin D: Germline p53 gene mutations and cancer: Pandora's box or open sesame? J Natl Cancer Inst 1994; 86: 326-328
2. Rowell S, Newman B, Boyd J et al: Inherited predisposition to breast and ovarian cancer. Am J Hum Genet 1994; 55: 861-865
3. Weber BL: Susceptibility genes for breast canter. N Engl J Med 1994; 331: 1523-1524
4. Wooster R, Neuhausen SL, Mangion J et al: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-2090
5. Robson C: Real World Research; a Resource for Social Scientists and Practitioner-Researchers, Blackwell, Oxford, England, 1993: 272-281
6. Nelkin D: The social power of genetic information. In Kevles DJ, Hood L (eds): The Code of Codes, Harvard University Press, Cambridge, Mass, 1992: 177-190
7. Miringoff ML: The Social Costs of Genetic Welfare, Rutgers University Press, New Brunswick, NJ, 1991: 41-62
8. Sorenson JR: Genetic counseling; values that have mattered. In Bartels DM, LeRoy BS, Caplan AL (eds): Prescribing Our Future: Ethical Challenges in Genetic Counseling, Aldine de Gruyter, Hawthorne, NY, 1993: 3-14
9. Croyle RT, Lerman C: Psychological impact of genetic testing. In Croyle RT (ed): Psychosocial Effects of Screening for Disease Prevention and Detection, Oxford University Press, New York, 1995: 11-38
10. Croyle RT, Jemmott JB: Psychological reactions to risk factor testing. In Skelton JA, Croyle RT (eds): Mental Representation in Health and Illness, Springer-Verlag, New York, 1991: 86-107
11. Bloch M, Fahy M, Fox S et al: Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet 1989; 32: 217-224
12. Lerman C, Croyle R: Psychological issues in genetic screening for breast cancer susceptibility. Arch Intern Med 1994; 154: 609-616
13. Lerman C, Daly M, Masny A et al: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994; 12: 843-850
14. Wardle J, Pope R: The psychological costs of screening for cancer. J Psychosom Res 1992; 36: 609-624
15. Lerman C, Rimer BK, Engstrom PF: Cancer risk notification: psychosocial and ethical implications. J Clin Oncol 1991; 9: 1275-1282
16. Vernon SW, Laville EA, Jackson GL: Participation in breast screening programs: a review. Soc Sci Med 1990; 30: 1107-1118
17. Bloch M, Adam S, Wiggins S et al: Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk. Am J Med Genet 992; 42: 499-507
18. Wiggins S, Whyte P, Huggins M et al: The psychological consequences of predictive testing for Huntington's disease. N Engl J Med 1992; 327: 1401-1405
19. Huggins M, Bloch M, Wiggins S et al: Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet 992; 42: 508-515
20. Biesecker BB, Boehnke M, Calzone K et al: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993; 269: 1970-1974
21. Eng C, Stratton M, Ponder B et al: Familial cancer syndromes. Lancet 1994; 343: 709-713
22. Evans DGR, Fentiman IS, McPherson K et al: Familial breast cancer. BMJ 1994; 308: 183-187
23. King M, Rowell S, Love SM: Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 1993; 269: 1975-1980
24. Lynch H, Watson P, Conway T el al: DNA screening for breast/ovarian cancer susceptibility based on linked markers: a family study. Arch Intern Med 1993; 153: 1979-1987
25. Antley RM: The genetic counselor as facilitator of the counselee's decision process. In Capron A, Lappe M, Murray RF Jr et al (eds): Genetic Counselling: Facts, Values and Norms, Arliss, New York: 1979: 51-84
26. Charo RA: Legal and regulatory issues surrounding carrier testing. Clin Obstet Gynecol 1993; 36: 568-597
27. Childs B, Gordis L, Kaback MM et al: Tay-Sachs screening: social and psychological impact. Am J Hum Genet 976; 28: 550-558
28. Marteau TM, van Duijn M, Ellis I: Effects of genetic screening on perceptions of health: a pilot study. J Med Genet 1992; 29: 24-26
29. Lerman C, Trock B, Rimer BK et al: Psychological side effects of breast cancer screening. Health Psychol 1991; 10: 259-267
30. Kelly P: Information needs of individuals and families with hereditary cancers. Semin Oncol Nurs 1992; 8: 288-292
31. Kelly PT: Risk counseling for relatives of cancer patients: new information, new approaches. J Psychosoc Oncol 1987; 5: 65-79
32. Naveed M, Phadke S, Sharma A et al: Sociocultural problems in genetic counselling. [letter] J Med Genet 1992; 29: 140-144
33. Punales-Morejon D, Penchaszadeh VB: Psychosocial aspects of genetic counseling: cross-cultural issues. Birth Defects 1992; 28: 11-15
34. Wang V, Marsh FH: Ethical principles and cultural integrity in health care delivery: Asian ethnocultural perspectives in genetic services. J Genet Couns 1992; 1: 81-92
35. Welshimer KJ, Earp JAL: Genetic counseling within the context of existing attitudes and beliefs. Patient Educ Couns 1989; 13: 237-255
36. Spinsanti S, Mazzarella P, Cattorini P et al: Obtaining consent from the family: a horizon tor clinical ethics. J Clin Ethics 1992; 3: 188-192
37. Draper E: Genetic secrets: social issues of medical screening in a genetic age. Hastings Cent Rep 1992; 22 (4): S15-S18
38. Hubbard R, Wald E: Exploding the Gene Myth, Beacon Press, Boston, Mass, 1993: 13-38, 72-107, 128-157
39. Resta RG: The twisted helix: an essay on genetic counselors, eugenics, and social responsibility. J Genet Couns 1992; 1: 227-243
40. Geller G, Tambor ES, Bernhardt BA et al: Physicians' attitudes toward disclosure of genetic information to third parties. J Law Med Ethics 1993; 21: 238-240
41. Clarke A: Is non-directive genetic counselling possible? Lancet 991; 338: 998-1001
42. Geller G, Holtzman NA: A qualitative assessment of primary care physicians' perceptions about the ethical and social implications of offering genetic testing. Qual Health Res 1995; 5 (1): 97-116
43. Fine BA: The evolution of nondirectiveness in genetic counseling and implications of the Human Genome Project. In Bartels DM, LeRoy BS, Caplan AL (eds): Prescribing Our Future: Ethical Challenges in Genetic Counseling, Aldine de Gruyter, Hawthorne, NY, 1993: 101-117
44. Kessler S: Psychological aspects of genetic counseling: VII. Thoughts on directiveness. J Genet Couns 1992; 1: 9-17
45. Annas GJ: Informed consent, cancer, and truth in prognosis. N Engl J Med 1994; 330: 223-225
46. Siminoff LA, Abeloff MD: Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol 1989; 7: 1192-1200
47. Somer M, Mustonen H, Norio R: Evaluation of genetic counselling: recall of information, post-counselling reproduction, and attitude of the counsellees. Clin Genet 1988; 34: 352-365
48. Wertz DC, Sorenson JR, Heeren TC: Clients' interpretation of risks provided in genetic counseling. Am J Hum Genet 986; 39: 253-264
49. Elias S, Annas GJ: Generic consent for genetic screening. N Engl J Med 1994; 330: 1611-1613
50. Lidz CW, Applebaum PS, Meisel A: Two models of implementing informed consent. Arch Intern Med 1988; 148: 1385-1389
51. Sharpe N: Informed consent and Huntington disease: a model for communication. Am J Med Genet 1994; 50: 239-246
52. Silva MC, Sorrell JM: Enhancing comprehension of information for informed consent: a review of empirical research. IRB Rev Hum Subj Res 1988; 10 (1): 1-5
53. Sorrell JM: Effects of writing/speaking on comprehension of information for informed consent. West J Nurs Res 1991; 13: 110-122
54. Lantos J: Informed consent: The whole truth for patients? Cancer 1993; 72 (9 suppl): 2811-2815
55. Wertz DC, Fletcher JC: Geneticists approach ethics: an international survey. Clin Genet 1993; 43: 104-110
56. Wertz DC, Fletcher JC, Mulvihill JJ: Medical geneticists confront ethical dilemmas: cross-cultural comparisons among 18 nations. Am J Hum Genet 990; 46: 1200-1213
57. Halliwell JE (chmn): Genetics in Canadian Health Can [report 42], Science Council of Canada, Ottawa, 1991: 1-14, 53-62, 63-80, 81-90
58. Bernhardt BA, Pyeritz RE: The economics of clinical genetics services: III. Cognitive genetics services are not self-supporting. Am J Hum Genet 989; 44: 288-293
59. Bernhardt BA, Weiner J, Foster EC et al: The economics of clinical genetics services: II. A time analysis of a medical genetics clinic. Am J Hum Genet 987; 41: 559-565
60. Pyeritz RE, Tumpson JE, Bernhardt BA: The economics of clinical genetics services: I. Preview. Am J Hum Genet 987; 41: 549-558
61. Andrews LB, Fullarton JE, Holtzman NA et al (eds): Assessing Genetic Risks: Implications for Health and Social Policy, National Academy Press, Washington, 1994: 185-201, 202-233, 247-281
62. Celler G, Tambor E, Hofman K: Incorporation of genetics in primary care practice: Will physicians do the counseling and will they be directive? Arch Fam Med 1993; 2: 1119-1125
63. Geller G, Holtzman NA: Implications of the human genome initiative for the primary care physician. Bioethics 1991; 5: 318-324
64. Rainer JD: Genetics for the clinician: a psychiatric view-point. Loss Grief Care 1989; 3: 1-13
65. Rubin S: Recognizing the patient at risk for genetic disease. Loss Grief Care 1989; 3: 131-143
66. Whittaker LA: The implications of the Human Genome Project for family practice. J Fam Pract 1992; 35: 294-301
67. Firth H, Lindenbaum R: UK clinicians' knowledge of and attitudes to the prenatal diagnosis of single gene disorders. J Med Genet 1992; 29: 20-23
68. Griffith RS, Williams PA. Barriers and incentives of physicians and patients to cancer screening. Prim Care 1992; 19: 535-556
69. Hofman KJ, Tambor ES, Chase GA et al: Physicians' knowledge of genetics and genetic tests. Acad Med 1993; 68: 625-631
70. Riccardi V, Schmickel R: Human genetics as a component of medical school curricula: a report of the American Society of Human Genetics. Am J Hum Genet 988; 42: 639-643
71. Geller G, Tambor ES, Chase GA et al: Measuring physicians' tolerance for ambiguity and its relationship to their reported practices regarding genetic testing. Med Care 1993; 31: 989-1001
72. Gerrity MS, DeVellis RF, Earp JL: Physicians' reactions to uncertainty in patient care: a new measure and new insights. Med Care 1990; 28: 724
73. Gerrity MS, Earp JL, DeVellis RG et al: Uncertainty and professional work: perceptions of physicians in clinical practice. Am J Social 1992; 97: 1022
74. Punales-Morejon D, Rapp R: Ethnocultural diversity and genetic counseling training: a challenge for the twenty-first century. J Genet Couns 1993; 2: 155-158
75. Smith SC, Warren NS, Misra L: Minority recruitment into the genetic counseling profession. J Genet Couns 1993; 2: 171-181
76. Weil J, Mittman I: A teaching framework for cross-cultural genetic counseling. J Genet Couns 1993; 2: 159-169
77. Miller JD: The Public Understanding of Science and Technology in the United States, 1990: a Report to the National Science Foundation, National Science Foundation, Washington, 1991: 4-22
78. Yeaton WH, Smith D, Rogers K: Evaluating understanding of popular press reports of health research. Health Educ Q 1990; 17: 223-234
79. Palmer CGS, Sainfort F: Toward a new conceptualization and operationalization of risk perception within the genetic counseling domain. J Genet Couns 1993; 2: 275-294
80. Robinson A: Genetic diagnosis: present and prospects. Can Med Assoc J 1994; 150: 49-52
81. Shiloh S, Saxe L: Perception of risk in genetic counseling. Psychol Health 1989; 3: 45-61
82. Singer E: Public attitudes toward genetic testing. Popul Res Policy Rev 1991; 10: 235-255
83. Singer E: Public attitudes toward fetal diagnosis and the termination of life. Soc Indic Res 1993; 28: 117-136
84. Quaid K, Morris M: Reluctance to undergo predictive testing: the case of Huntington's disease. Am J Med Genet 1993; 45: 41-45
85. Croyle RT, Lerman C: Interest in genetic testing for colon canter susceptibility: cognitive and emotional correlates. Prev Med 1993; 22: 284-292
86. Moens F: Familial ovarian cancer: screening and prevention. Can J Contin Med Educ 1994; 6 (4): 33-44
87. Breo DL: Altered fates: counseling families with inherited breast cancer. JAMA 1993; 269: 2017-2022
88. Ganz PA, Schag AG, Lee JJ et al: Breast conservation versus mastectomy: Is there a difference in psychological adjustment on quality of life in the year after surgery? Cancer 1992; 69: 1727-1738
89. Daly MB, Lerman C: Ovarian cancer risk counseling: a guide for the practitioner. Oncology (Huntingt) 1993; 7: 27-41
90. Evans D, Ribiero G, Warrell D et al: Ovarian cancer: family and prophylactic choices. J Med Genet 1992; 29: 416-418
91. Green J, Murton F, Stratham H: Psychosocial issues raised by a familial ovarian cancer register. J Med Genet 1993; 30: 575-579
92. Kerlikowske K, Brown JS, Grady DG: Should women with familial ovarian cancer undergo prophylactic oophorectomy? [review] Obstet Gynecol 1992; 80: 700-707
93. Schlesselman JJ: Cancer of the breast and reproductive tract in relation to use of oral contraceptives. Contraception 1989; 40: 1-27
94. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development: The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 1987; 316: 650-655
95. Nayfield SG, Karp JE, Ford LG et al: Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 1991; 83: 1450-1459
96. Clarke A (chmn): The genetic testing of children. J Med Genet 1994; 1: 785-797
97. Marteau TM: The genetic testing of children. J Med Genet 1994; 31: 743
98. Wertz DC, Fanos JH, Reilly PR: Genetic testing for children and adolescents: Who decides? JAMA 1994; 272: 875-881
99. Bloch M, Hayden MR: Predictive testing for Huntington disease in childhood: challenges and implications. Am J Hum Genet 990; 46: 1-4
100. Clayton EW: Screening and treatment of newborns. Houston Law Rev 1992; 29: 85-148
101. Harper PS, Clarke A: Should we test children for "adult" genetic diseases? Lancet 990; 335: 1205-1206
102. Sharpe N: Presymptomatic testing for Huntington disease: Is there a duty to test those under the age of eighteen years? Am J Med Genet 1993; 46: 250-253
103. Knoppers BM: Human Dignity and Genetic Heritage, Law Reform Commission of Canada, Ottawa, 1991
104. Knoppers BM, Chadwick R: The Human Genome Project: under an international ethical microscope. Science 1994; 265 (Sept 30): 2035-2036
105. Cook-Deegan RM: Public policy implications of the Human Genome Project. In Bankowski Z, Capron AM (eds): Genetics, Ethics and Human Values [proceedings], Council for International Organizations of Medical Sciences, Bethesda, Md, 1991: 56-71
106. Dickens BM: Some legal and ethical implications of genetic predictability. Transpl/Implantation Today, 1990; Sept 7: 24-30
107. Draper E: High-risk workers or high-risk work? Genetic susceptibility policies in the hazardous workplace. Int J Social Soc Policy 1986; 6: 12-29
108. Cohen MM: Genetic testing and insurance. Am J Hum Genet 995; 56: 327-331
109. Hubbard R, Wald E: Looking for gay genes. Genewatch 1993; 8 (1): 6-7
110. Keller EF: Nature, nurture, and the Human Genome Project. In Kevles DJ, Hood L (eds): The Code of Codes, Harvard University Press, Cambridge, Mass, 1992: 281-299
111. Nelkin D, Tancredi L: Classify and control: genetic information in the schools. Am J Law Med 1991; 17: 51-73
112. Tauber AI, Sarkar S: The Human Genome Project: Has blind reductionism gone too far? Perspect Biol Med 1992; 35: 220-235
113. Annas GJ, Elias S: The major social policy issues raised by the Human Genome Project. In Annas GJ, Elias S (eds): Gene Mapping: Using Law and Ethics as Guides, Oxford University Press, New York: 1992: 3-17
114. Garver KL, Garver B: Eugenics: past, present, and the future. Am J Hum Genet 991; 49: 1109-1118
115. Billings PR, Kohn MA, de Cuevas M et al: Discrimination as a consequence of genetic testing. Am J Hum Genet 992; 50: 476-482
116. Miringoff M: Genetic intervention and the problem of stigma. Policy Stud Rev 1989; 8: 389-404
117. Wexler N: Clairvoyance and caution: repercussions from the Human Genome Project. In Kevles DJ, Hood L (eds): The Code of Codes, Harvard University Press, Cambridge, Mass, 1992: 211-243
118. National Advisory Council for Human Genome Research: Statement on use of DNA testing tor presymptomatic identification of cancer risk. JAMA 1994; 271: 785
119. Holtzman NA: Benefits and risks of emerging genetic technologies: the need for regulation. [review] Clin Chem 1994; 40: 1652-1657
120. Kahn P: Role of public policy in genetic screening and counseling. In Bartels DM, LeRoy BS, Caplan AL (eds): Prescribing Our Future: Ethical Challenges in Genetic Counseling, Aldine de Gruyter, Hawthorne, NY, 1993: 79-87
121. Truesdell-Smith E, Bartels DM: Introduction. In Bartels DM, LeRoy BS, Caplan AL (eds): Prescribing Our Future: Ethical Challenges in Genetic Counseling, Aldine de Gruyter, Hawthorne, NY, 1993: xv-xix
122. Wilfond BS, Nolan K: National policy development for the clinical application of genetic diagnostic technologies: lessons from cystic fibrosis. JAMA 1993; 270: 2948-2954
123. Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991; 48: 232-242
124. Easton DF, Bishop DT, Ford D et al and the Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678-701